Figure 2From: Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study Summary of safety assessments with the intradermal and adjuvanted vaccines on days 0-7 post-vaccination. (a) Incidence of all and of severe solicited injection-site reactions. (b) Incidence of solicited systemic reactionsBack to article page